Why the study?
A simplified, systematic approach was needed to help clinicians focus on the most relevant 2020 updates and recommendations for optimizing cardiovascular disease prevention.
Key points are not available for this paper at this time.
Design
Review
Answers are grounded in this paper and cite their sources.
Helps clinicians track 2020 preventive updates; leaves open need for prospective outcome trials.
In recent years, improvement in outcomes related to cardiovascular disease is in part due to the prioritization and progress of primary and secondary prevention efforts. The Johns Hopkins Ciccarone Center for the Prevention of Cardiovascular Disease expanded 'ABC's approach is used to highlight key findings in Preventive Cardiology from 2020 and further emphasize the importance of cardiovascular prevention. This simplified approach helps clinicians focus on the most relevant and up to date recommendations for optimizing cardiovascular disease risk through accurate risk assessment and appropriate implementation of lifestyle, behavioral and pharmacologic interventions. While 2020 not only provided practice changing updates by way of clinical guidelines and randomized controlled trials on topics related to antithrombotic and lipid lowering therapy, diabetes management and risk assessment, it also provided promising data on how to improve dietary and exercise adherence and manage genetic risk. By providing clinicians with a systematic approach to cardiovascular prevention and key highlights from the prior year, the goal of significantly reducing the burden of cardiovascular disease worldwide can be achieved.
No takes yet. Share an insight, caveat, or question.
Feldman et al. (2021) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: